Apomorphine-induced reorganization of striato-frontal connectivity in patients with tremor-dominant Parkinson's disease

Parkinsonism Relat Disord. 2019 Oct:67:14-20. doi: 10.1016/j.parkreldis.2019.09.006. Epub 2019 Sep 8.

Abstract

Introduction: Apomorphine is a dopamine agonist used in Parkinson's disease (PD), which matches levodopa in terms of the magnitude of effect on the cardinal motor features, such as tremor and bradykinesia. The beneficial effect of this treatment on PD patients with tremor-dominant has widely been demonstrated, although the underlying neural correlates are unknown. We sought to examine the effects of apomorphine on topological characteristics of resting-state functional connectivity networks in tremor-dominant PD (tdPD) patients.

Methods: Sixteen tdPD patients were examined using a combined electromyography-functional magnetic resonance imaging approach. Patients were scanned twice following either placebo (subcutaneous injection of 1 mL saline solution) or 1 mg of apomorphine injection. Graph analysis methods were employed to investigate the modular organization of functional connectivity networks before and after drug treatment.

Results: After injection of apomorphine, evident reduction of tremor symptoms was mirrored by a significant increase in overall connectivity strength and reorganization of the modular structure of the basal ganglia and of the fronto-striatal module. Moreover, we found an increase in the centrality of motor and premotor regions. No differences were found between pre- and post-placebo sessions.

Conclusion: These results provide new evidence about the effects of apomorphine at a large-scale neural network level showing that drug treatment modifies the brain functional organization of tdPD, increasing the overall resting-state functional connectivity strength, the segregation of striato-frontal regions and the integrative role of motor areas.

Keywords: Apomorphine; Community detection; Graph theory; Resting-state fMRI; Tremor-dominant Parkinson's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apomorphine / pharmacology*
  • Apomorphine / therapeutic use
  • Dopamine Agonists / pharmacology*
  • Dopamine Agonists / therapeutic use
  • Electromyography
  • Female
  • Frontal Lobe / diagnostic imaging
  • Frontal Lobe / drug effects*
  • Frontal Lobe / physiopathology
  • Functional Neuroimaging
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neostriatum / diagnostic imaging
  • Neostriatum / drug effects*
  • Neostriatum / physiopathology
  • Neural Pathways / diagnostic imaging
  • Neural Pathways / drug effects
  • Neural Pathways / physiopathology
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / physiopathology
  • Single-Blind Method
  • Tremor / diagnostic imaging
  • Tremor / drug therapy*
  • Tremor / physiopathology

Substances

  • Dopamine Agonists
  • Apomorphine